Agentic AI for healthcare interoperability and data liquidity
Agentic AI has captured the imagination of healthcare leaders because it promises something the industry has struggled to deliver at scale: moving from information to action. An agent should not just summarize a chart or answer a question. It should help book an appointment, guide a patient through a care plan, support prior authorization workflows, surface the right clinical guideline at the right moment and coordinate activity across a fragmented care journey.
But that promise breaks down quickly when data is trapped in silos.
Across providers, payers and life sciences organizations, leaders are discovering the same truth: **AI will stall if systems cannot exchange the right information safely, in context and at the moment action is needed.** That is why “API before AI” matters. Before an agent can do useful work, organizations need a practical, standards-based way for systems, services and partners to connect.
Why API before AI is the real starting point
Much of the excitement around agentic AI focuses on models. In reality, the model is only part of the equation. The harder work is building the infrastructure, permissions, governance and orchestration that allow agents to operate safely on behalf of clinicians, nurses, care teams and patients.
In healthcare, that starts with data maturity and interoperability.
If a scheduling agent cannot access appointment availability, benefits context, referral status and patient preferences, it cannot complete the task. If a care navigation agent cannot see the care plan, medication list, recent encounters and payer requirements, it cannot guide the next best step with confidence. If a prior authorization support agent cannot retrieve medical necessity criteria or connect diagnosis, procedure and documentation data, it can only generate partial answers and more administrative burden.
This is the shift leaders need to recognize: agentic AI is not a chatbot strategy. It is an action strategy. And action requires APIs, permissions and trusted access to data.
Fragmented data is the biggest barrier to meaningful agents
Healthcare organizations have spent years discussing interoperability, yet fragmentation remains one of the industry’s biggest structural constraints. Data sits across EHRs, claims platforms, imaging systems, contact centers, pharmacy systems, revenue cycle tools and life sciences environments. Even within a single enterprise, information is often difficult to access in a reusable way. Across the ecosystem, the problem becomes much more severe.
One perspective shared by industry leaders is especially telling: less than 3% of healthcare data is effectively used today because of fragmentation and silos. When agents depend on timely, contextual data, that is not just an IT issue. It is a strategic blocker.
Without data liquidity:
- patients still face friction when trying to find the right care and book it
- clinicians still waste time searching, reconciling and documenting across disconnected systems
- care managers still struggle to coordinate longitudinal journeys across settings
- prior authorization teams still work through manual, document-heavy processes
- life sciences organizations still face barriers in connecting real-world evidence, services and research participation to patient-consented workflows
This is why interoperability should no longer be framed as a back-office modernization program. It is the bedrock for patient-facing and clinician-facing AI use cases.
The use cases leaders care about depend on exchange, not just intelligence
The most compelling agentic AI use cases in healthcare are not abstract. They are operational, measurable and close to the patient or clinician workflow.
Consider a patient trying to schedule preventive screening. The friction is familiar: determine whether screening is due, confirm coverage, identify an appropriate site of care, find an available slot and complete the booking. An agent can bridge that complexity only if it can access the right sources across provider and payer environments.
The same applies to:
- **Appointment booking and triage:** helping patients determine what type of care they need, where to go and how to get on the schedule
- **Care plan navigation:** translating complex instructions into clear next steps based on patient context and changing health status
- **Prior authorization support:** checking requirements, surfacing medical necessity guidelines and preparing documentation flows faster
- **Longitudinal care coordination:** connecting encounters, handoffs, medications, referrals and follow-up tasks across the continuum
- **Clinical decision support:** grounding agents in trusted guidelines and summarizing the right context for clinicians without forcing them to hunt through systems
These experiences may feel “intelligent” on the surface, but their real value comes from connected workflows. The smoother the workflow runs with the agent than without it, the closer the use case is to production value.
Data liquidity without exposing everything
One reason interoperability efforts often stall is the fear that openness means surrendering control. It does not.
Healthcare leaders need partnership models that enable exchange without requiring every organization to expose all of its raw data. That is where modern shared-access approaches matter.
A more practical model is emerging:
- expose **standards-based APIs** rather than entire source systems
- share **specific data products, permissions and conclusions** instead of unrestricted raw datasets
- use **consumer-mediated exchange** so patients can authorize where and how their data is shared
- create **shared orchestration layers** with common guardrails, monitoring and auditability
- design **permission-aware agents** so each agent can only access the data and tools appropriate to its role
This approach is especially important across providers, payers and life sciences organizations, where trust, privacy and competitive concerns are real. The answer is not radical openness. The answer is controlled liquidity.
In practice, that means an agent may not need every note, every claim line or every research record. It may only need verified eligibility, a medication summary, a referral status, a consented longitudinal view or the relevant rule set to perform a defined task. That is enough to unlock action while preserving governance.
Consumer-mediated exchange can reshape the ecosystem
The most important shift may be philosophical as much as technical.
For years, healthcare has debated who “owns” the data. Agentic AI raises the stakes on that question because the value of an agent depends on whether it can follow the person across fragmented interactions. A consumer-mediated model changes the equation by allowing patients to authorize trusted exchange across the organizations involved in their care and health journey.
That creates a more scalable path for ecosystem collaboration:
- providers gain richer context beyond episodic encounters
- payers can support navigation, authorization and care management with better precision
- life sciences organizations can participate in patient-centered services and research models more responsibly
- patients gain a more coherent experience without forcing every institution into the same stack
For leaders, this opens the door to new partnership models centered on value creation rather than data hoarding.
Trust, governance and shared operations matter as much as the model
Healthcare will move at the speed of trust. That makes interoperability a governance issue as much as a technology issue.
Organizations that want to scale agentic AI need more than APIs. They need a shared operational layer with:
- common guardrails
- auditable system access
- workflow clarity
- human-in-the-loop escalation points
- red teaming and adversarial testing
- monitoring for security, bias and reliability
They also need cross-functional ownership. Too many initiatives stall when technology teams build in isolation from business, clinical and operational leaders. The most effective starting points are the ones where stakeholders align around a high-frequency problem, a contained workflow and a measurable outcome.
Interoperability is now a growth and experience agenda
The industry has spent too long treating interoperability as a compliance exercise or a back-office integration burden. In an agentic AI era, that view is outdated.
Interoperability is how healthcare creates capacity. It is how clinicians get time back. It is how patients face less friction. It is how prior authorization becomes less manual. It is how longitudinal coordination becomes possible. It is how organizations design more connected, more human healthcare experiences.
The next wave of healthcare advantage will not come from deploying isolated agents into disconnected systems. It will come from building the platform, API and partnership foundations that let agents act safely, responsibly and across the ecosystem.
In other words: no meaningful AI without data liquidity, and no data liquidity without interoperability.
For leaders across providers, payers and life sciences, that is the real strategic imperative now.